We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$628M
AUM Growth
-$105M
Cap. Flow
-$132M
Cap. Flow %
-21%
Top 10 Hldgs %
31.66%
Holding
141
New
23
Increased
28
Reduced
42
Closed
26

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$23.5M
2
NVMI
Nova
NVMI
+$11.1M
3
APLS
Apellis Pharmaceuticals
APLS
+$7.99M
4
VKTX icon
Viking Therapeutics
VKTX
+$7.81M
5
CHKP icon
Check Point Software Technologies
CHKP
+$7.36M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$28.3M
2
CYTK icon
Cytokinetics
CYTK
+$8.91M
3
CRM icon
Salesforce
CRM
+$8.64M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$7.08M
5
ASML icon
ASML
ASML
+$6.31M

Sector Composition

Rank Sector Weight
1 Healthcare 70%
2 Technology 19.18%
3 Consumer Discretionary 3.53%
4 Communication Services 2.96%
5 Utilities 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATX icon
26
Perspective Therapeutics
CATX
$332M
$7.87M 1.25%
589,295
-197,614
-25% -$2.63M
CHKP icon
27
Check Point Software Technologies
CHKP
$13B
$7.75M 1.23%
+40,215
New +$7.36M
ABBV icon
28
AbbVie
ABBV
$443B
$7.5M 1.19%
38,000
– –
MRUS
29
DELISTED
Merus
MRUS
$7.38M 1.17%
147,633
– –
ENPH icon
30
Enphase Energy
ENPH
$4.96B
$7.26M 1.16%
64,224
+7,432
+13% +$830K
MRK icon
31
Merck
MRK
$322B
$6.77M 1.08%
59,600
– –
BHVN icon
32
Biohaven
BHVN
$2.03B
$6.66M 1.06%
+133,323
New +$5.19M
S icon
33
SentinelOne
S
$6.53B
$6.62M 1.05%
276,554
-7,250
-3% -$164K
MRVL icon
34
Marvell Technology
MRVL
$168B
$6.32M 1.01%
87,611
+67,611
+338% +$4.67M
INZY
35
DELISTED
Inozyme Pharma
INZY
$6.23M 0.99%
1,191,140
-271,584
-19% -$1.41M
APLS
36
DELISTED
Apellis Pharmaceuticals
APLS
$6.23M 0.99%
+215,873
New +$7.99M
SKYE icon
37
Skye Bioscience
SKYE
$20M
$6.11M 0.97%
1,563,522
+265,210
+20% +$1.49M
NTLA icon
38
Intellia Therapeutics
NTLA
$1.49B
$5.98M 0.95%
291,080
+151,661
+109% +$3.5M
RZLT icon
39
Rezolute
RZLT
$454M
$5.81M 0.92%
1,196,938
-511,061
-30% -$2.35M
NVS icon
40
Novartis
NVS
$297B
$5.75M 0.92%
50,000
– –
WIX icon
41
WIX.com
WIX
$2.3B
$5.73M 0.91%
34,253
+9,076
+36% +$1.46M
VIGL
42
DELISTED
Vigil Neuroscience
VIGL
$5.6M 0.89%
1,647,604
-44,562
-3% -$165K
NICE icon
43
CALL
Nice
NICE
$5.79B
$5.57M 0.89%
32,100
– –
DAWN
44
DELISTED
Day One Biopharmaceuticals
DAWN
$4.84M 0.77%
347,627
– –
BIIB icon
45
Biogen
BIIB
$30B
$4.74M 0.75%
24,455
-22,957
-48% -$4.8M
PTCT icon
46
PTC Therapeutics
PTCT
$5.68B
$4.39M 0.7%
118,345
+24,027
+25% +$804K
RCKT icon
47
Rocket Pharmaceuticals
RCKT
$340M
$4.28M 0.68%
231,792
+24,859
+12% +$509K
GSK icon
48
GSK
GSK
$104B
$4.09M 0.65%
100,000
– –
ETNB
49
DELISTED
89bio
ETNB
$3.97M 0.63%
536,547
+10,000
+2% +$84.1K
ACAD icon
50
Acadia Pharmaceuticals
ACAD
$4.43B
$3.88M 0.62%
252,539
-75,000
-23% -$1.25M
1
2
3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sphera Funds Management held 141 positions worth $628M, down 14% from $733M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q3 2024, closing 26 positions and reducing 42 holdings. Its most notable exit was Salesforce, an estimated $8.64M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 59% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Nova worth $10.8M.

  • Sphera Funds Management's largest Q3 2024 buy was Nova: 51,960 shares worth $10.8M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q3 2024, an estimated $23.5M increase.
  • Sphera Funds Management's biggest Q3 2024 reduction was Broadcom, cutting an estimated $28.3M.
  • Sphera Funds Management fully exited Salesforce in Q3 2024, selling an estimated $8.64M.
  • Sphera Funds Management's ten largest holdings make up 32% of its $628M portfolio in Q3 2024.
  • Sphera Funds Management opened 23 new positions and closed 26 in Q3 2024.
  • Sphera Funds Management's portfolio value fell 14% quarter-over-quarter to $628M.

Based on Sphera Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.